Supporting the breakthroughs that change lives

The Goodman Foundation has committed $2.8 million over five years to support the AllClear research program led by the Garvan Institute of Medical Research, helping advance research aimed at preventing breast cancer recurrence and improving outcomes for patients and their families.
The Goodman Foundation focuses on providing life's essentials to people who need them most, investing in initiatives that improve health, wellbeing and opportunity in the communities where we operate. 

Its commitment to the AllClear program reflects this approach, helping advance world-leading research into one of the greatest challenges in breast cancer treatment: preventing the disease from returning after successful treatment. 
AllClear brings together leading researchers, clinicians and institutions from Australia and around the world to better understand how dormant cancer cells can remain hidden in the body and later cause a relapse. 

Researchers aim to develop new tests and therapies that can identify and eliminate these cells before breast cancer returns. 

Alison Brink, Chair of the Goodman Foundation, said "Our focus is on supporting innovative, long-term solutions that create a meaningful and sustainable impact. We’re incredibly proud to join the National Breast Cancer Foundation and the exceptional researchers at the Garvan Institute to support AllClear, which is aiming to transform cancer care through technology and innovation, delivering life-changing benefits for patients and their families.”
AllClear is a collaboration involving almost 60 researchers across leading research institutes, hospitals and universities, with the shared goal of preventing breast cancer relapse. 

Professor Benjamin Kile, Executive Director and CEO of the Garvan Institute of Medical Research, said " “We're proud to welcome the Goodman Foundation as a community partner in the AllClear program. The commitment of Goodman is a very generous thing to do, and we don't take it lightly. Long-term commitments like theirs give our researchers the stability to pursue the most difficult scientific questions and turn those discoveries into real outcomes for patients.”
By investing in medical research and innovation, the Goodman Foundation is helping advance breakthroughs that have the potential to improve lives and create lasting benefits for patients, families and communities. 

Learn more about the impact of AI in medical research in our Thought Starters episode featuring Professor Sarah Kummerfeld and Associate Professor Christine Chaffer from the Garvan Institute of Medical Research.